Literature DB >> 7495348

Primary Sjögren's syndrome in men.

J M Anaya1, G T Liu, E D'Souza, N Ogawa, X Luan, N Talal.   

Abstract

OBJECTIVE: To describe the clinical expression of primary Sjögren's syndrome (SS) in men, focusing on extraglandular manifestations (EGM) and serological markers of disease.
METHODS: In a cross sectional and comparative study, adult men with primary SS were identified from a cohort study on SS, and 26 age matched adult women with primary SS were selected as a control group. All patients met the European classification criteria for SS. They were compared for demographic, clinical and laboratory findings.
RESULTS: Thirteen men with primary SS were identified. Mean age at onset was 39 (SEM 4) years and mean duration of disease was 7.8 (1) years. Sicca complex or parotitis was the presenting feature in eight patients (61.5%), and an EGM in five (38.5%). During the course of the disease, EGM were present in 12 patients (92%), polyarthralgias and lymphopenia being the most frequent (38.5% each). Rheumatoid factor was positive in 73% of patients, antinuclear antibodies in 85%, anti-(SS-A) in 62%, and anti-(SS-B) in 46%. No statistical differences in the frequency of EGM or in the presence of autoantibodies were observed between men and women. However, men patients were more likely to have EGM.
CONCLUSION: Primary SS in men is an uncommon condition with clinical and serological characteristics similar to those observed in women. Sex hormones may be incriminated in the pathogenesis of SS. However, it remains poorly understood whether sex hormones play a major role in the severity of disease and have any importance with regard to treatment.

Entities:  

Mesh:

Year:  1995        PMID: 7495348      PMCID: PMC1009992          DOI: 10.1136/ard.54.9.748

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  14 in total

1.  Raynaud's phenomenon in primary Sjögren's syndrome. Association with other extraglandular manifestations.

Authors:  A Kraus; C Caballero-Uribe; J Jakez; A R Villa; D Alarcón-Segovia
Journal:  J Rheumatol       Date:  1992-10       Impact factor: 4.666

2.  Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community.

Authors:  C Vitali; S Bombardieri; H M Moutsopoulos; G Balestrieri; W Bencivelli; R M Bernstein; K B Bjerrum; S Braga; J Coll; S de Vita
Journal:  Arthritis Rheum       Date:  1993-03

3.  Antineuronal antibodies in patients with neurologic complications of primary Sjögren's syndrome.

Authors:  J W Moll; H M Markusse; J J Pijnenburg; C J Vecht; S C Henzen-Logmans
Journal:  Neurology       Date:  1993-12       Impact factor: 9.910

4.  Pleuropulmonary abnormalities in primary Sjögren's syndrome.

Authors:  P Gardiner; C Ward; A Allison; T Ashcroft; W Simpson; H Walters; C Kelly
Journal:  J Rheumatol       Date:  1993-05       Impact factor: 4.666

5.  Sjögren's syndrome: association of anti-Ro(SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity.

Authors:  E L Alexander; F C Arnett; T T Provost; M B Stevens
Journal:  Ann Intern Med       Date:  1983-02       Impact factor: 25.391

6.  Phenotypic and functional abnormalities in the peripheral blood T-cells of patients with primary Sjogren's syndrome.

Authors:  K E Aziz; P J McCluskey; D Wakefield
Journal:  Cytometry       Date:  1994-03-15

Review 7.  Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action.

Authors:  S Ansar Ahmed; W J Penhale; N Talal
Journal:  Am J Pathol       Date:  1985-12       Impact factor: 4.307

8.  Primary Sjögren's syndrome in men. Clinical, serologic, and immunogenetic features.

Authors:  R Molina; T T Provost; F C Arnett; W B Bias; M C Hochberg; R W Wilson; E L Alexander
Journal:  Am J Med       Date:  1986-01       Impact factor: 4.965

9.  Chronic neutropenia: possible association with Sjögren's syndrome.

Authors:  G Starkebaum; J T Dancey; W P Arend
Journal:  J Rheumatol       Date:  1981 Jul-Aug       Impact factor: 4.666

10.  Two patients illustrating lymphoma transition and response to therapy in Sjögren's syndrome.

Authors:  N Talal; T B Aufdemorte; W L Kincaid; B S Sayers; J T Lynn
Journal:  J Autoimmun       Date:  1988-04       Impact factor: 7.094

View more
  10 in total

Review 1.  Autoimmune heart disease: role of sex hormones and autoantibodies in disease pathogenesis.

Authors:  DeLisa Fairweather; Michelle A Petri; Michael J Coronado; Leslie T Cooper
Journal:  Expert Rev Clin Immunol       Date:  2012-03       Impact factor: 4.473

2.  Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome.

Authors:  V Goëb; V Salle; P Duhaut; F Jouen; A Smail; J-P Ducroix; F Tron; X Le Loët; O Vittecoq
Journal:  Clin Exp Immunol       Date:  2007-02-07       Impact factor: 4.330

3.  Sjögren's syndrome: History, clinical and pathological features.

Authors:  A L Parke; W W Buchanan
Journal:  Inflammopharmacology       Date:  1998       Impact factor: 4.473

4.  Primary Sjögren's syndrome in men: clinical and immunological characteristic based on a large cohort of Hungarian patients.

Authors:  Ildiko Fanny Horvath; Peter Szodoray; Margit Zeher
Journal:  Clin Rheumatol       Date:  2008-06-14       Impact factor: 2.980

Review 5.  Lymphopenia and autoimmune diseases.

Authors:  Hendrik Schulze-Koops
Journal:  Arthritis Res Ther       Date:  2004-06-22       Impact factor: 5.156

6.  Primary Sjögren syndrome in Han Chinese: clinical and immunological characteristics of 483 patients.

Authors:  Yun Zhao; Ya Li; Li Wang; Xiao-Feng Li; Ci-Bo Huang; Guo-Chun Wang; Xue-Wu Zhang; Zhuo-Li Zhang; Xiao Zhang; Wei-Guo Xiao; Lie Dai; Yong-Fu Wang; Shao-Xian Hu; Hong-Bin Li; Lu Gong; Bin Liu; Ling-Yun Sun; Miao-Jia Zhang; Xuan Zhang; Yong-Zhe Li; De-Shun Du; Shun-Hua Zhang; Yuan-Yuan Sun; Feng-Chun Zhang
Journal:  Medicine (Baltimore)       Date:  2015-04       Impact factor: 1.889

Review 7.  A systematic review of primary Sjögren's syndrome in male and paediatric populations.

Authors:  Simrun Virdee; James Greenan-Barrett; Coziana Ciurtin
Journal:  Clin Rheumatol       Date:  2017-07-22       Impact factor: 2.980

8.  Difference in clinical presentation between women and men in incident primary Sjögren's syndrome.

Authors:  Jorge I Ramírez Sepúlveda; Marika Kvarnström; Susanna Brauner; Chiara Baldini; Marie Wahren-Herlenius
Journal:  Biol Sex Differ       Date:  2017-05-12       Impact factor: 5.027

9.  Sjögren's syndrome.

Authors:  Fiona André; Barbara C Böckle
Journal:  J Dtsch Dermatol Ges       Date:  2022-07-01       Impact factor: 5.231

Review 10.  Sex differences in Sjögren's syndrome: a comprehensive review of immune mechanisms.

Authors:  Jessica E Brandt; Roberta Priori; Guido Valesini; DeLisa Fairweather
Journal:  Biol Sex Differ       Date:  2015-11-03       Impact factor: 5.027

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.